Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent review of COVID-19 management: diagnosis, treatment and vaccination
Vivek P. Chavda, Suneetha Vuppu, Toshika Mishra, et al.
Pharmacological Reports (2022) Vol. 74, Iss. 6, pp. 1120-1148
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Nanoparticle-Based Delivery Systems for Vaccines
Rajashri Bezbaruah, Vivek P. Chavda, Lawandashisha Nongrang, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1946-1946
Open Access | Times Cited: 124
The Delta and Omicron Variants of SARS-CoV-2: What We Know So Far
Vivek P. Chavda, Rajashri Bezbaruah, Kangkan Deka, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1926-1926
Open Access | Times Cited: 71
Nanovaccines: A game changing approach in the fight against infectious diseases
Priyanka Choudhary, Mai Abdel Haleem Abusalah, Hitesh Chopra, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115597-115597
Open Access | Times Cited: 59
Adenoviral Vector-Based Vaccine Platform for COVID-19: Current Status
Vivek P. Chavda, Rajashri Bezbaruah, Disha Valu, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 432-432
Open Access | Times Cited: 49
mRNA-Based Vaccine for COVID-19: They Are New but Not Unknown!
Vivek P. Chavda, Gargi Jogi, Srusti Dave, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 507-507
Open Access | Times Cited: 30
Conventional and Novel Diagnostic Tools for the Diagnosis of Emerging SARS-CoV-2 Variants
Vivek P. Chavda, Disha Valu, Palak K. Parikh, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 374-374
Open Access | Times Cited: 29
Molnupiravir: A Versatile Prodrug against SARS-CoV-2 Variants
Divya Teli, Pankti C. Balar, Kishan Patel, et al.
Metabolites (2023) Vol. 13, Iss. 2, pp. 309-309
Open Access | Times Cited: 25
Comorbidities of COVID-19 Patients
Radu Silaghi‐Dumitrescu, Iulia Patrascu, Maria Lehene, et al.
Medicina (2023) Vol. 59, Iss. 8, pp. 1393-1393
Open Access | Times Cited: 19
Exploring the Potential of Nanotechnology in Pediatric Healthcare: Advances, Challenges, and Future Directions
Hossein Omidian, Kwadwo Mfoafo
Pharmaceutics (2023) Vol. 15, Iss. 6, pp. 1583-1583
Open Access | Times Cited: 18
The Impact of Vaccination on COVID-19 Burden of Disease in the Adult and Elderly Population: A Systematic Review of Italian Evidence
Giovanna Elisa Calabrò, C. Pappalardo, Floriana D’Ambrosio, et al.
Vaccines (2023) Vol. 11, Iss. 5, pp. 1011-1011
Open Access | Times Cited: 17
Convalescent plasma (hyperimmune immunoglobulin) for COVID-19 management: An update
Vivek P. Chavda, Rajashri Bezbaruah, Sheetal Dolia, et al.
Process Biochemistry (2023) Vol. 127, pp. 66-81
Open Access | Times Cited: 16
Effectiveness and safety of azvudine in older adults with mild and moderate COVID-19: a retrospective observational study
Zhiguo Zhou, He Zheng, Gui’e Xiao, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Conventional vaccination methods: Inactivated and live attenuated vaccines
Terrick Andey, Shailvi Soni, Shail Modi
Elsevier eBooks (2024), pp. 37-50
Closed Access | Times Cited: 5
An optimized data analytics pipeline for improving healthcare diagnosis using ensemble learning
Lomat Haider Chowdhury, Shaira Tabassum, Swakkhar Shatabda, et al.
Informatics in Medicine Unlocked (2025) Vol. 53, pp. 101623-101623
Open Access
Pharmacogenomic Study of SARS-CoV-2 Treatments: Identifying Polymorphisms Associated with Treatment Response in COVID-19 Patients
Alex Serra-Llovich, Natàlia Cullell, Olalla Maroñas, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 553-553
Open Access
Fast screening of COVID-19 inpatient samples by integrating machine learning and label-free SERS methods
Jaya Sitjar, Huey‐Pin Tsai, Han Lee, et al.
Analytica Chimica Acta (2025) Vol. 1350, pp. 343872-343872
Closed Access
Biomimetic lung-on-a-chip to model virus infection and drug evaluation
Jianfeng Tan, Quanwei Guo, Lingling Tian, et al.
European Journal of Pharmaceutical Sciences (2022) Vol. 180, pp. 106329-106329
Open Access | Times Cited: 22
Regulatory processes involved in clinical trials and intellectual property rights around vaccine development
Nimeet Desai, Shreya Pande, Amol D. Gholap, et al.
Elsevier eBooks (2024), pp. 279-309
Closed Access | Times Cited: 4
Hybrid feature engineering of medical data via variational autoencoders with triplet loss: a COVID-19 prognosis study
Mahdi Mahdavi, Hadi Choubdar, Zahra Rostami, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Transforming health care systems towards high-performance organizations: qualitative study based on learning from COVID-19 pandemic in the Basque Country (Spain)
Ane Fullaondo, Irati Erreguerena, Esteban de Manuel Keenoy
BMC Health Services Research (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Enhancement efficiency delivery of antiviral Molnupiravir-drug via the loading with self-assembly nanoparticles of pycnogenol and cellulose which are decorated by zinc oxide nanoparticles for COVID-19 therapy
Nagi M. El‐Shafai, Yasser S. Mostafa, Mohamed S. Ramadan, et al.
Bioorganic Chemistry (2023) Vol. 143, pp. 107028-107028
Closed Access | Times Cited: 9
The Vaccine World of COVID-19: India’s Contribution
Vivek P. Chavda, Disha R. Vihol, Hetvi K. Solanki, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1943-1943
Open Access | Times Cited: 15
Leveraging SARS-CoV-2 Main Protease (Mpro) for COVID-19 Mitigation with Selenium-Based Inhibitors
Viviana De Luca, Andrea Angeli, Alessio Nocentini, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 971-971
Open Access | Times Cited: 2
Reviewing the insights of SARS-CoV-2: Its epidemiology, pathophysiology, and potential preventive measures in traditional medicinal system
Munish Sharma, Amit Sharma, Simran Sharma, et al.
Deleted Journal (2024) Vol. 5, Iss. 2, pp. 200147-200147
Open Access | Times Cited: 2
Use of Hand Sanitizers in COVID-19 Prevention: A Comprehensive Overview
Suneetha Vuppu, Toshika Mishra, Arjun Chinamgari
Pharmacoepidemiology (2023) Vol. 2, Iss. 3, pp. 257-271
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top